Rise of Biologics
Biologic therapies have profoundly reshaped patient care, particularly in oncology, immunology, and the treatment of rare diseases. This discussion will highlight recent advancements in biologics, including innovations in monoclonal antibody development and major breakthroughs in gene therapy. It will also examine challenges associated with biologic drug development, the growing role of biosimilars, and the potential of combination therapies to improve treatment effectiveness.
Sub-Sessions:
- Monoclonal Antibodies in Disease Treatment
- Gene Therapy Breakthroughs
- Biosimilars: The Future of Biologics
- Biologic Drug Development Challenges
- Biologic Combination Therapies